Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014 (2014), Article ID 628473, 8 pages
http://dx.doi.org/10.1155/2014/628473
Research Article

Antidiabetic Effects of Carassius auratus Complex Formula in High Fat Diet Combined Streptozotocin-Induced Diabetic Mice

1Medical Center of Aging Research, China Medical University Hospital, No. 91, Hsueh-Shih Road, Taichung 40402, Taiwan
2School of Nutrition, Chung Shan Medical University, No. 110, Sec. 1, Chien Kuo North Road, Taichung, 40201, Taiwan
3Department of Medical Research, Chung Shan Medical University Hospital, No. 110, Sec. 1, Chien Kuo North Road, Taichung 40201, Taiwan
4School of Medical Laboratory and Biotechnology, Chung Shan Medical University, No. 110, Sec. 1, Chien Kuo North Road, Taichung 40201, Taiwan

Received 24 October 2013; Accepted 13 December 2013; Published 8 January 2014

Academic Editor: Bor-Show Tzang

Copyright © 2014 Zhi-Hong Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. N. Gouda, G. S. Sagoo, A.-H. Harding, J. Yates, M. S. Sandhu, and J. P. T. Higgins, “The association between the peroxisome proliferator-activated receptor-γ2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis,” American Journal of Epidemiology, vol. 171, no. 6, pp. 645–655, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. A. S. Attele, Y.-P. Zhou, J.-T. Xie et al., “Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component,” Diabetes, vol. 51, no. 6, pp. 1851–1858, 2002. View at Google Scholar · View at Scopus
  3. C. Hug and H. F. Lodish, “The role of the adipocyte hormone adiponectin in cardiovascular disease,” Current Opinion in Pharmacology, vol. 5, no. 2, pp. 129–134, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. P. E. Scherer, “Adipose tissue: from lipid storage compartment to endocrine organ,” Diabetes, vol. 55, no. 6, pp. 1537–1545, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Kadowaki, T. Yamauchi, N. Kubota, K. Hara, K. Ueki, and K. Tobe, “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome,” Journal of Clinical Investigation, vol. 116, no. 7, pp. 1784–1792, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. C. M. Steppan, S. T. Bailey, S. Bhat et al., “The hormone resistin links obesity to diabetes,” Nature, vol. 409, no. 6818, pp. 307–312, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. S. S. Pang and Y. Y. Le, “Role of resistin in inflammation and inflammation-related diseases,” Cellular & Molecular Immunology, vol. 3, no. 1, pp. 29–34, 2006. View at Google Scholar · View at Scopus
  8. Z. A. Kamenov, R. A. Parapunova, and R. T. Georgieva, “Earlier development of diabetic neuropathy in men than in women with type 2 diabetes mellitus,” Gender Medicine, vol. 7, no. 6, pp. 600–615, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Rossing, “Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history,” Current Diabetes Reports, vol. 6, no. 6, pp. 479–483, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Romero-Aroca, J. Fernández-Balart, M. Baget-Bernaldiz et al., “Changes in the diabetic retinopathy epidemiology after 14 years in a population of Type 1 and 2 diabetic patients after the new diabetes mellitus diagnosis criteria and a more strict control of the patients,” Journal of Diabetes and Its Complications, vol. 23, no. 4, pp. 229–238, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. C. E. Grimshaw, K. M. Bohren, C.-J. Lai, and K. H. Gabbay, “Human aldose reductase: pK of tyrosine 48 reveals the preferred ionization state for catalysis and inhibition,” Biochemistry, vol. 34, no. 44, pp. 14374–14384, 1995. View at Publisher · View at Google Scholar · View at Scopus
  12. A. E. Raptis and G. Viberti, “Pathogenesis of diabetic nephropathy,” Experimental and Clinical Endocrinology and Diabetes, vol. 109, supplement 2, pp. S424–S437, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Oyama, Y. Miyasita, H. Watanabe, and K. Shirai, “The role of polyol pathway in high glucose-induced endothelial cell damages,” Diabetes Research and Clinical Practice, vol. 73, no. 3, pp. 227–234, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. S. S. M. Chung and S. K. Chung, “Aldose reductase in diabetic microvascular complications,” Current Drug Targets, vol. 6, no. 4, pp. 475–486, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Yamauchi, J. Kamon, H. Waki et al., “The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance,” The Journal of Biological Chemistry, vol. 276, no. 44, pp. 41245–41254, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. J. K. Grover, S. Yadav, and V. Vats, “Medicinal plants of India with anti-diabetic potential,” Journal of Ethnopharmacology, vol. 81, no. 1, pp. 81–100, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. R. J. Marles and N. R. Farnsworth, “Antidiabetic plants and their active constituents,” Phytomedicine, vol. 2, no. 2, pp. 137–189, 1995. View at Google Scholar · View at Scopus
  18. X.-S. Shu, J.-H. Lv, J. Tao, G.-M. Li, H.-D. Li, and N. Ma, “Antihyperglycemic effects of total flavonoids from Polygonatum odoratum in STZ and alloxan-induced diabetic rats,” Journal of Ethnopharmacology, vol. 124, no. 3, pp. 539–543, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. W. W. Liu, T. Ogata, S. Sato, K. Unoura, and J.-I. Onodera, “Superoxide scavenging activities of sixty Chinese medicines determined by an ESR spin-trapping method using electrogenerated superoxide,” Yakugaku Zasshi, vol. 121, no. 4, pp. 265–270, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. H. A. Jung, Y. J. Jung, N. Y. Yoon et al., “Inhibitory effects of Nelumbo nucifera leaves on rat lens aldose reductase, advanced glycation endproducts formation, and oxidative stress,” Food and Chemical Toxicology, vol. 46, no. 12, pp. 3818–3826, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. X. Gao, B. Li, H. Jiang, F. Liu, D. Xu, and Z. Liu, “Dioscorea opposita reverses dexamethasone induced insulin resistance,” Fitoterapia, vol. 78, no. 1, pp. 12–15, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. C. L. Lin, C. C. Wang, S. C. Chang, B. S. Inbaraj, and B. H. Chen, “Antioxidative activity of polysaccharide fractions isolated from Lycium barbarum Linnaeus,” International Journal of Biological Macromolecules, vol. 45, no. 2, pp. 146–151, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. W.-J. Huang, H.-S. Niu, M.-H. Lin, J.-T. Cheng, and F.-L. Hsu, “Antihyperglycemic effect of catalpol in streptozotocin-induced diabetic rats,” Journal of Natural Products, vol. 73, no. 6, pp. 1170–1172, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Srinivasan, B. Viswanad, L. Asrat, C. L. Kaul, and P. Ramarao, “Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening,” Pharmacological Research, vol. 52, no. 4, pp. 313–320, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Wang, T. Campbell, B. Perry, C. Beaurepaire, and L. Qin, “Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats,” Metabolism, vol. 60, no. 2, pp. 298–305, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent,” The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at Google Scholar · View at Scopus
  27. J. Folch, M. Lees, and S. G. H. Sloane, “A simple method for the isolation and purification of total lipides from animal tissues,” The Journal of Biological Chemistry, vol. 226, no. 1, pp. 497–509, 1957. View at Google Scholar · View at Scopus
  28. Y. S. Kim, N. H. Kim, D. H. Jung et al., “Genistein inhibits aldose reductase activity and high glucose-induced TGF-β2 expression in human lens epithelial cells,” European Journal of Pharmacology, vol. 594, no. 1–3, pp. 18–25, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Nishinaka and C. Yabe-Nishimura, “EGF receptor-ERK pathway is the major signaling pathway that mediates upregulation of aldose reductase expression under oxidative stress,” Free Radical Biology and Medicine, vol. 31, no. 2, pp. 205–216, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. J. R. Baker, P. A. Metcalf, and R. N. Johnson, “Use of protein-based standards in automated colorimetric determinations of fructosamine in serum,” Clinical Chemistry, vol. 31, no. 9, pp. 1550–1554, 1985. View at Google Scholar · View at Scopus
  31. J. R. Petrie, E. R. Pearson, and C. Sutherland, “Implications of genome wide association studies for the understanding of type 2 diabetes pathophysiology,” Biochemical Pharmacology, vol. 81, no. 4, pp. 471–477, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. B. B. Lowell and G. I. Shulman, “Mitochondrial dysfunction and type 2 diabetes,” Science, vol. 307, no. 5708, pp. 384–387, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Shi and D. Cheng, “Beyond triglyceride synthesis: the dynamic functional roles of MGAT and DGAT enzymes in energy metabolism,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 297, no. 1, pp. E10–E18, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Nkondjock and O. Receveur, “Fish-seafood consumption, obesity, and risk of type 2 diabetes: an ecological study,” Diabetes and Metabolism, vol. 29, no. 6, pp. 635–642, 2003. View at Google Scholar · View at Scopus
  35. D. Fedor and D. S. Kelley, “Prevention of insulin resistance by n-3 polyunsaturated fatty acids,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 12, no. 2, pp. 138–146, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Nanri, T. Mizoue, M. Noda et al., “Fish intake and type 2 diabetes in Japanese men and women: the Japan Public Health Center-based prospective study,” The American Journal of Clinical Nutrition, vol. 94, no. 3, pp. 884–891, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. P. G. McTernan, C. L. McTernan, R. Chetty et al., “Increased resistin gene and protein expression in human abdominal adipose tissue,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 5, pp. 2407–2410, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Slawik and A. J. Vidal-Puig, “Lipotoxicity, overnutrition and energy metabolism in aging,” Ageing Research Reviews, vol. 5, no. 2, pp. 144–164, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. E. E. Kershaw and J. S. Flier, “Adipose tissue as an endocrine organ,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2548–2556, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. J.-P. Bastard, M. Maachi, C. Lagathu et al., “Recent advances in the relationship between obesity, inflammation, and insulin resistance,” European Cytokine Network, vol. 17, no. 1, pp. 4–12, 2006. View at Google Scholar · View at Scopus
  41. T. Yamauchi, J. Kamon, H. Waki et al., “The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity,” Nature Medicine, vol. 7, no. 8, pp. 941–946, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. U.S. Department of Health and Human Services, Diabetes: A National Plan for Action, pp. 19–22, U.S. Department of Health and Human Services, 2004.
  43. R. G. Gonzalez, P. Barnett, and J. Aguayo, “Direct measurement of polyol pathway activity in the ocular lens,” Diabetes, vol. 33, no. 2, pp. 196–199, 1984. View at Google Scholar · View at Scopus
  44. K. V. Ramana, D. Chandra, S. Srivastava, A. Bhatnagar, and S. K. Srivastava, “Nitric oxide regulates the polyol pathway of glucose metabolism in vascular smooth muscle cells,” The FASEB Journal, vol. 17, no. 3, pp. 417–425, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. J. P. Shield, K. Poyser, L. Hunt, and C. A. Pennock, “Fructosamine and glycated haemoglobin in the assessment of long term glycaemic control in diabetes,” Archives of Disease in Childhood, vol. 71, no. 5, pp. 443–445, 1994. View at Google Scholar · View at Scopus
  46. “Diabetes UK. HbA1c (Glycated haemoglobin) and fructosamine,” 2011, http://www.diabetes.org.uk/hba1c.
  47. A. P. Robertson, “Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes,” The Journal of Biological Chemistry, vol. 279, no. 41, pp. 42351–42354, 2004. View at Publisher · View at Google Scholar · View at Scopus